Artificial intelligence is rapidly transforming molecular design and drug discovery. The Computational Pharmacy group at the University of Basel focuses on developing next-generation AI approaches for drug design by combining state-of-the-art machine learning with physicochemical knowledge and molecular modeling. A fully funded Postdoctoral position is available within an international Innosuisse research project on AI-driven closed-loop drug discovery. The project aims to establish an integrated Design–Make–Test–Analyze (DMTA) platform combining generative AI, ultra-large synthetically accessible chemical spaces, physics-informed molecular representations, off-target prediction, and experimental feedback.
Dieses Unternehmensprofil wurde automatisch erstellt. Wenn du für Universität Basel arbeitest, kannst du das Profil jetzt beanspruchen und verifizieren – kostenlos und in wenigen Minuten.
You will work closely with computational scientists, chemists, and biologists within an international project consortium and collaborate with industrial partners.